Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Patients typically start with 0.25 mg weekly for four weeks, then increase to 0.5 mg, 1 mg, 1.7 mg, and finally the maintenance dose of 2.4 mg weekly
Understanding these patterns helps set appropriate expectations based on individual circumstances
The SUMMIT trial found that tirzepatide, a long-acting agonist of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, reduced the risk of the co-primary outcome a composite of death from cardiovascular causes or a worsening heart failure event by 38% versus placebo
But semaglutide-assisted weight loss can lighten the load on your cardiovascular system
US$ 21.78
US$ 21.41
US$ 23.25
US$ 26.57
US$ 24.54
